Putting 225 years of legal experience and innovation to work today.

2017 Year in Review: Corporate Governance Litigation & Regulation

In 2017, Delaware courts issued decisions that have fundamentally altered corporate governance litigation. We discuss the most significant judicial and regulatory developments in our year-end review.

2017 Year in Review: Securities Litigation and Regulation

Plaintiffs filed 226 new federal class actions in the first half of 2017, more than double the average rate over the last 20 years, and an additional 99 federal class actions in the third quarter.

Cadwalader Represents New Mexico Health Connections in Sale of Group Health Business to Evolent Health

The Cadwalader team includes Stephanie Marcantonio, Bill Mills, Paul Mourning, Peter Bariso, Michael DiFiore, Gianna Sagan, David Teigman, Linda Swartz, Jean Bertrand, Dorothy Auth and Michael Sebba.

Cadwalader Advises The Howard Hughes Corporation in Connection with Underwritten Public Secondary Offering

The Cadwalader team is led by Richard Brand, Braden McCurrach and Matthew Sadofsky, and includes Mattan Erder, Victoria Saunders and Edward Wei.

Cadwalader Represents Sompo International in its Agreement to Acquire Lexon Surety Group

The firm is representing the Bermuda-based specialty provider of property and casualty insurance and reinsurance in its agreement to purchase the operating subsidiaries of Lexon Surety Group LLC.

Cadwalader Named 2018 Securitization ‘Firm of the Year’ by The Legal 500 UK

The firm was named the 2018 "Finance Firm of the Year” for Securitization by The Legal 500 UK.

Cadwalader Elects Nine New Partners and Promotes Five New Special Counsel and Counsel

"These are outstanding lawyers with an unwavering commitment to client service and demonstrated excellence,” said Pat Quinn, Cadwalader’s Managing Partner.

Cadwalader Represents The Medicines Company in Agreement to Sell its Infectious Disease Business

Cadwalader is representing The Medicines Company in its agreement to sell its infectious disease business unit to Melinta Therapeutics, Inc.

Cadwalader News

ACI Summit on Controlled Substances: Regulation, Litigation and Enforcement

Jodi Avergun is speaking at this ACI event on January 30 in Washington, DC.

Cadwalader Subscription Center